Concepedia

Gregory Sahagian

GS

Statistics

Publications

9

Citations

1.8K

H-Index

9

Active since

1990

Affiliations

Neurology Center of Southern California(Current)

University Health Network

University of Toronto

The University of Texas Southwestern Medical Center

University of South Florida

Gregory Sahagian is an author at Neurology Center of Southern California specializing in life sciences, pharmacotherapy, and immunotherapy.

ORCID

Publications per year

1990–2025

9

Publications

9

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

James F. Howard, Vera Bril, Tuan Vu et al. · The Lancet Neurology · 2021 · 668 citations · Full text

, , +4

Randomized Double-blind Study Comparing the Efficacy of Gabapentin With Amitriptyline on Diabetic Peripheral Neuropathy Pain

Candis M. Morello, Susan G. Leckband, Carol P. Stoner et al. · Archives of Internal Medicine · 1999 · 444 citations

, , +17

Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study

Volkan Granit, Michael Benatar, Metin Kurtoğlu et al. · The Lancet Neurology · 2023 · 256 citations · Full text

, , +11

Skin Biopsy Detection of Phosphorylated α-Synuclein in Patients With Synucleinopathies

Christopher H. Gibbons, Todd Levine, Charles H. Adler et al. · JAMA · 2024 · 180 citations · Full text

, , +17

Amyloid-β <sup>11</sup> C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials

Enchi Liu, Mark E. Schmidt, Richard Margolin et al. · Neurology · 2015 · 152 citations · Full text

, , +17

1–5 of 9